Despite intensive effort to understand the brain substrates of cocaine addiction through biochemical investigations in the experimental animal, the cause of cocaine addiction remains unknown. We suggest that such neurochemical studies should also be conducted in brain of the human cocaine user. In an autopsied brain study of ten cocaine users, we observed reduced concentration of a specific neurotransmitter, dopamine (DA), in the nucleus accumbens--a brain area suggested to be involved in mediating both the acute and long-term effects of cocaine.
The SPECIFIC AIMS of our proposed investigation are to examine the reliability and reversibility, cause, and drug and neurochemical specificities of the DA reduction. Our major HYPOTHESIS to be tested is that withdrawal from cocaine and other drugs of abuse will be associated with reductions in levels of nucleus accumbens DA, DA biosynthetic enzymes, and DA transporter, that are eventually reversed. This hypothesis will be tested through biochemical examination, by HPLC, Western Blot, and autoradiographic approaches, of levels of DA, the DA biosynthetic enzymes tyrosine hydroxylase and DOPA decarboxylase, and the DA transporter in autopsied brain of a minimum of ten cocaine, five opiate, five methamphetamine, and five alcohol users during each of the three years of our investigation. A special feature of this study is our ability to obtain, from U.S. medical examiners, autopsied brain of drug users characterized with respect to drug type, duration, and pattern. We expect that the results of our investigation will provide a robust test of the """"""""DA depletion hypothesis of cocaine addiction"""""""" and, at the same time, will address the important medical issue of cocaine toxicity to human brain DA neurones. Ultimately, this information will help to clarify the contribution of the nucleus accumbens DA system to the behavioral consequences, and possibly causes, of cocaine use in the human and contribute to the development of new brain region-based approaches to the problem of drug addiction.
| Tong, Junchao; Fitzmaurice, Paul S; Moszczynska, Anna et al. (2018) Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine. Drug Alcohol Depend 190:20-28 |
| Tong, Junchao; Ang, Lee-Cyn; Williams, Belinda et al. (2015) Low levels of astroglial markers in Parkinson's disease: relationship to ?-synuclein accumulation. Neurobiol Dis 82:243-253 |
| Tong, Junchao; Fitzmaurice, Paul; Furukawa, Yoshiaki et al. (2014) Is brain gliosis a characteristic of chronic methamphetamine use in the human? Neurobiol Dis 67:107-18 |
| Pifl, Christian; Kish, Stephen J; Hornykiewicz, Oleh (2012) Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms. Mov Disord 27:1618-24 |
| Tong, Junchao; Furukawa, Yoshiaki; Sherwin, Allan et al. (2011) Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain. Neurobiol Dis 41:458-68 |
| Kish, S J; Fitzmaurice, P S; Chang, L J et al. (2010) Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study. J Psychopharmacol 24:281-4 |
| Kish, Stephen J; Fitzmaurice, Paul S; Boileau, Isabelle et al. (2009) Brain serotonin transporter in human methamphetamine users. Psychopharmacology (Berl) 202:649-61 |
| Frankel, Paul S; Alburges, Mario E; Bush, Lloyd et al. (2008) Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users. Neuropharmacology 55:41-6 |
| Kish, Stephen J; Tong, Junchao; Hornykiewicz, Oleh et al. (2008) Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 131:120-31 |
| Frankel, Paul S; Alburges, Mario E; Bush, Lloyd et al. (2007) Brain levels of neuropeptides in human chronic methamphetamine users. Neuropharmacology 53:447-54 |
Showing the most recent 10 out of 14 publications
